NE
Neogen Chemicals Limited
NEOGEN.BO · BSE
₹2,265.00 +2.24% (+₹49.60)
1M +1.48%
Market Cap ₹58.4B
P/E Ratio 164.12x
Div. Yield 0.05%
ROE 4.40%
Bulios Fair Price
₹1,456
35.7% downside
Current Price
₹2,265
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NEOGEN.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/E 164.12x
EV/EBITDA 36.66x
P/S 6.31x
Growth
48 /100
Stable EPS growth 18.37%
Rev. growth 7.90%
Book val. growth 19.15%
Profitability
54 /100
Moderate Gross margin 39.52%
Net margin 3.84%
Op. margin 13.40%
Quality
34 /100
Average ROE 4.40%
ROIC N/A
ROA N/A
Debt
83 /100
Low Debt/Equity 0.00x
Int. coverage 1.55x
Net debt/EBITDA 0.00x
Stability
85 /100
Stable Beta 0.66x
Rev. volatility 6.45%
EPS volatility 12.45%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NEOGEN.BO
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Harin Haridas Kanani
Employees
680
Headquarters
Thane
Upcoming events
09 NOV
Earnings
Upcoming earnings report